Catalyst Wire Dossier Catalyst Wire Dossier

oportuzumab monatox

oportuzumab monatox · DLRC Pharma Services Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for oportuzumab monatox, covering 2021-10-20 to 2021-10-20. Get the full timeline:

Most recent: EMA Application withdrawn: Oportuzumab monatox DLRC Pharma Services (oportuzumab monatox) — DLRC Pharma Services Ltd

See pricing